Sepsis Testing Accuracy Technology Enables Enhanced Patient Safety, Experience and Satisfaction Steripath can eliminate unnecessary venipunctures by enabling blood culture draws from peripheral IV starts News provided by Share this article ®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination, 1 announced today continued clinical efficacy data supporting multiple, peer-reviewed clinical studies that confirm zero or near-zero false-positive rates from blood cultures drawn from peripheral intravenous (PIV) starts. These data signify that patient harm from avoidable venipunctures and sepsis misdiagnosis can be prevented. Sepsis is a complex and aggressive syndrome impacting at least 1.7 million people in the U.S. annually of which nearly 270,000 die.